Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3176 |
|
| Actual shortage: | 259 (8%) | |
| Anticipated shortage: | 5 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2903 (91%) | |
Discontinuation Reports |
355 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 333 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
33 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Actual shortage | 2024-09-20 | 2024-09-20 | 238245 |
| APO-CLONAZEPAM | 0.5MG | TABLET | Actual shortage | 2024-09-20 | 2024-09-20 | 238242 |
| APO-RIVASTIGMINE | 6MG | CAPSULE | Actual shortage | 2024-09-20 | 2024-09-20 | 238239 |
| APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-09-20 | 2024-09-20 | 238236 |
| APO-CANDESARTAN TABLETS | 16MG | TABLET | Actual shortage | 2024-09-20 | 2024-09-20 | 238233 |
| APO-DESMOPRESSIN | 0.2MG | TABLET | Actual shortage | 2024-09-20 | 2024-09-20 | 238230 |
| APO-DASATINIB | 100MG | TABLET | Resolved | 2024-09-12 | 2024-09-20 | 237354 |
| ALYSENA 21 | 20MCG 100MCG | TABLET | Resolved | 2024-09-12 | 2024-09-20 | 237351 |
| APO-SITAGLIPTIN MALATE | 25MG | TABLET | Actual shortage | 2024-08-29 | 2024-09-20 | 236246 |
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2024-08-29 | 2024-09-20 | 236255 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2024-08-29 | 2024-09-20 | 236237 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2024-09-05 | 2024-09-20 | 236864 |
| MIRVALA 28 | 0.0300MG 0.1500MG | TABLET | Actual shortage | 2024-08-22 | 2024-09-20 | 235701 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Actual shortage | 2024-08-01 | 2024-09-20 | 234280 |
| APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-08-01 | 2024-09-20 | 234271 |
| APO-HYDROXYQUINE | 200MG | TABLET | Resolved | 2024-07-18 | 2024-09-20 | 233330 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-08-22 | 2024-09-20 | 235692 |
| APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-07-05 | 2024-09-20 | 232335 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-07-18 | 2024-09-20 | 233325 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 850MG 50MG | TABLET | Actual shortage | 2024-07-05 | 2024-09-20 | 232324 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
| APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
| APO-METOCLOP TAB 5MG | 5mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1105 |
| APO-METOCLOP TAB 10MG | 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1101 |
| APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
| APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-DILTIAZ TZ | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1078 |
| APO-DILTIAZ TZ | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1075 |
| APO-DILTIAZ TZ | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1072 |
| APO-DILTIAZ TZ | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1069 |
| APO-DILTIAZ TZ | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1064 |
| APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |